Metabolomics: An essential tool to understand the function of peroxisome proliferator-activated receptor alpha

Jessica E. Montanez, Jeffrey Maurice Peters, Jared B. Correll, Frank J. Gonzalez, Andrew David Patterson

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

The peroxisome proliferator-activated receptor (PPAR) family of nuclear hormone transcription factors (PPARα, PPARβ/δ, and PPARγ) is regulated by a wide array of ligands including natural and synthetic chemicals. PPARs have important roles in control of energy metabolism and are known to influence inflammation, differentiation, carcinogenesis, and chemical toxicity. As such, PPARs have been targeted as therapy for common disorders such as cancer, metabolic syndrome, obesity, and diabetes. The recent application of metabolomics, or the global, unbiased measurement of small molecules found in biofluids, or extracts from cells, tissues, or organisms, has advanced our understanding of the varied and important roles that the PPARs have in normal physiology as well as in pathophysiological processes. Continued development and refinement of analytical platforms, and the application of new bioinformatics strategies, have accelerated the widespread use of metabolomics and have allowed further integration of small molecules into systems biology. Recent studies using metabolomics to understand PPARα function, as well as to identify PPARα biomarkers associated with drug efficacy/toxicity and drug-induced liver injury, will be discussed.

Original languageEnglish (US)
Pages (from-to)410-418
Number of pages9
JournalToxicologic Pathology
Volume41
Issue number2
DOIs
StatePublished - Feb 1 2013

Fingerprint

PPAR alpha
Peroxisome Proliferator-Activated Receptors
Metabolomics
Toxicity
Chemical and Drug Induced Liver Injury
Molecules
Tissue Extracts
Systems Biology
Physiology
Biomarkers
Bioinformatics
Medical problems
Cell Extracts
Computational Biology
Drug-Related Side Effects and Adverse Reactions
Nuclear Family
Pharmaceutical Preparations
Liver
Energy Metabolism
Carcinogenesis

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Molecular Biology
  • Toxicology
  • Cell Biology

Cite this

@article{bd5e364f4c6646149ccb7355507b7b34,
title = "Metabolomics: An essential tool to understand the function of peroxisome proliferator-activated receptor alpha",
abstract = "The peroxisome proliferator-activated receptor (PPAR) family of nuclear hormone transcription factors (PPARα, PPARβ/δ, and PPARγ) is regulated by a wide array of ligands including natural and synthetic chemicals. PPARs have important roles in control of energy metabolism and are known to influence inflammation, differentiation, carcinogenesis, and chemical toxicity. As such, PPARs have been targeted as therapy for common disorders such as cancer, metabolic syndrome, obesity, and diabetes. The recent application of metabolomics, or the global, unbiased measurement of small molecules found in biofluids, or extracts from cells, tissues, or organisms, has advanced our understanding of the varied and important roles that the PPARs have in normal physiology as well as in pathophysiological processes. Continued development and refinement of analytical platforms, and the application of new bioinformatics strategies, have accelerated the widespread use of metabolomics and have allowed further integration of small molecules into systems biology. Recent studies using metabolomics to understand PPARα function, as well as to identify PPARα biomarkers associated with drug efficacy/toxicity and drug-induced liver injury, will be discussed.",
author = "Montanez, {Jessica E.} and Peters, {Jeffrey Maurice} and Correll, {Jared B.} and Gonzalez, {Frank J.} and Patterson, {Andrew David}",
year = "2013",
month = "2",
day = "1",
doi = "10.1177/0192623312466960",
language = "English (US)",
volume = "41",
pages = "410--418",
journal = "Toxicologic Pathology",
issn = "0192-6233",
publisher = "SAGE Publications Inc.",
number = "2",

}

Metabolomics : An essential tool to understand the function of peroxisome proliferator-activated receptor alpha. / Montanez, Jessica E.; Peters, Jeffrey Maurice; Correll, Jared B.; Gonzalez, Frank J.; Patterson, Andrew David.

In: Toxicologic Pathology, Vol. 41, No. 2, 01.02.2013, p. 410-418.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Metabolomics

T2 - An essential tool to understand the function of peroxisome proliferator-activated receptor alpha

AU - Montanez, Jessica E.

AU - Peters, Jeffrey Maurice

AU - Correll, Jared B.

AU - Gonzalez, Frank J.

AU - Patterson, Andrew David

PY - 2013/2/1

Y1 - 2013/2/1

N2 - The peroxisome proliferator-activated receptor (PPAR) family of nuclear hormone transcription factors (PPARα, PPARβ/δ, and PPARγ) is regulated by a wide array of ligands including natural and synthetic chemicals. PPARs have important roles in control of energy metabolism and are known to influence inflammation, differentiation, carcinogenesis, and chemical toxicity. As such, PPARs have been targeted as therapy for common disorders such as cancer, metabolic syndrome, obesity, and diabetes. The recent application of metabolomics, or the global, unbiased measurement of small molecules found in biofluids, or extracts from cells, tissues, or organisms, has advanced our understanding of the varied and important roles that the PPARs have in normal physiology as well as in pathophysiological processes. Continued development and refinement of analytical platforms, and the application of new bioinformatics strategies, have accelerated the widespread use of metabolomics and have allowed further integration of small molecules into systems biology. Recent studies using metabolomics to understand PPARα function, as well as to identify PPARα biomarkers associated with drug efficacy/toxicity and drug-induced liver injury, will be discussed.

AB - The peroxisome proliferator-activated receptor (PPAR) family of nuclear hormone transcription factors (PPARα, PPARβ/δ, and PPARγ) is regulated by a wide array of ligands including natural and synthetic chemicals. PPARs have important roles in control of energy metabolism and are known to influence inflammation, differentiation, carcinogenesis, and chemical toxicity. As such, PPARs have been targeted as therapy for common disorders such as cancer, metabolic syndrome, obesity, and diabetes. The recent application of metabolomics, or the global, unbiased measurement of small molecules found in biofluids, or extracts from cells, tissues, or organisms, has advanced our understanding of the varied and important roles that the PPARs have in normal physiology as well as in pathophysiological processes. Continued development and refinement of analytical platforms, and the application of new bioinformatics strategies, have accelerated the widespread use of metabolomics and have allowed further integration of small molecules into systems biology. Recent studies using metabolomics to understand PPARα function, as well as to identify PPARα biomarkers associated with drug efficacy/toxicity and drug-induced liver injury, will be discussed.

UR - http://www.scopus.com/inward/record.url?scp=84875733856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875733856&partnerID=8YFLogxK

U2 - 10.1177/0192623312466960

DO - 10.1177/0192623312466960

M3 - Review article

C2 - 23197196

AN - SCOPUS:84875733856

VL - 41

SP - 410

EP - 418

JO - Toxicologic Pathology

JF - Toxicologic Pathology

SN - 0192-6233

IS - 2

ER -